This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://dx.doi.org/10.1002/1097-0142(19931215)72:12%2B%3C3870::
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q72636469
rdf:type
wikibase:Item
schema:description
scientific article published on 01 December 1993 наукова стаття, опублікована в грудні 1993 wetenschappelijk artikel im Dezember 1993 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'avientu de 1993
p:P577
wds:Q72636469-C749CE4E-6650-4F5D-9BAB-6EF1037C3148
wdt:P577
1993-12-01T00:00:00Z
p:P407
wds:Q72636469-E1B2F8D8-F429-4A30-8BAC-63403C6E2EE9
wdt:P407
wd:Q1860
p:P2093
wds:Q72636469-CA76176D-59B5-4C71-9E37-DD4492B81C89 wds:Q72636469-3983A790-0C3C-474B-B55F-B1FD46D6793F wds:Q72636469-586EF45C-D112-4C9C-BB73-66E881AA359E wds:Q72636469-6BCC5316-1364-4B39-9D06-1C9D6F9CEE11 wds:Q72636469-C5BDA67F-A6EA-4DD1-94D9-2EB086A9E3BE wds:Q72636469-BA6113EE-9F5B-4639-9F05-C0ADDF269628 wds:Q72636469-FFC741C6-5387-49B4-BE11-E77A8B7143A1
wdt:P2093
M A Eisenberger D G McLeod J T Spaulding E D Crawford D Spicer B A Blumenstein R C Benson
rdfs:label
The use of flutamide in hormone-refractory metastatic prostate cancer The use of flutamide in hormone-refractory metastatic prostate cancer
skos:prefLabel
The use of flutamide in hormone-refractory metastatic prostate cancer The use of flutamide in hormone-refractory metastatic prostate cancer
schema:name
The use of flutamide in hormone-refractory metastatic prostate cancer The use of flutamide in hormone-refractory metastatic prostate cancer
p:P1476
wds:Q72636469-9B2AB526-7170-4C2C-908A-FD268F58DDAB
wdt:P1476
The use of flutamide in hormone-refractory metastatic prostate cancer
p:P304
wds:Q72636469-00D07E8D-58BE-4B93-914B-CBA311B960D4
wdt:P304
3870-3873
p:P31
wds:Q72636469-2FA87857-344F-43B6-9AE2-553EFC771C6D
wdt:P31
wd:Q13442814
p:P921
wds:Q72636469-A93FFCFF-C5C5-43FE-AB3F-6A8E5DD6AD77
wdt:P921
wd:Q181257
p:P698
wds:Q72636469-27B6A72E-CC68-43F7-8E13-4BAEA4075368
wdtn:P698
n12:8252506
wdt:P698
8252506
p:P1433
wds:Q72636469-147FBE10-9406-47CD-821A-D107B452DEC1
wdt:P1433
wd:Q326041
p:P433
wds:Q72636469-333EAE6F-0591-42C1-B4CC-417E87618BB0
p:P478
wds:Q72636469-48D35A2F-88C9-4EE0-BEA1-08FA52D0AC7D
wdt:P433
12 Suppl
wdt:P478
72
p:P356
wds:Q72636469-907A7962-3663-46E5-A10C-A0FB3902F5CE
wdtn:P356
n9:AID-CNCR2820721721%3E3.0.CO;2-E
wdt:P356
10.1002/1097-0142(19931215)72:12+<3870::AID-CNCR2820721721>3.0.CO;2-E